ConductScience.org, home

Paper39598451

Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis.

Morgan GJ and 4 others. Pharmaceuticals (Basel), 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis. Papers, record 39598451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39598451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis.
PubMed
Journal
Pharmaceuticals (Basel)
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.6, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morgan GJGareth Jhttps://orcid.org/0000-0002-1275-2010
2Yung ZZach
3Spencer BHBrian Hhttps://orcid.org/0000-0002-2182-5170
4Sanchorawala VVaishalihttps://orcid.org/0000-0002-6307-2445
5Prokaeva TTatianahttps://orcid.org/0000-0002-0790-602X

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R25 HL118693NHLBI NIH HHSUnited StatesR25HL118693PubMed and NIHNIH RePORTER
2R25HL118693-11A1NIH HHSUnited StatesR25HL118693PubMed and NIHNIH RePORTER
1UL1TR001430-07S1NIH HHSUnited StatesUL1TR001430PubMed and NIHNIH RePORTER
P01 HL068705NHLBI NIH HHSUnited StatesP01HL068705PubMedNIH RePORTER
UL1 TR001430NCATS NIH HHSUnited StatesUL1TR001430PubMed and NIHNIH RePORTER

Download CSV of grants

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121495850Protein folding and modification in the mammalian endoplasmic reticulum.Annu Rev Biochem2011https://conductscience.org/library/papers/21495850PubMed
230894521Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.Nat Commun2019https://conductscience.org/library/papers/30894521PubMed
330894526Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.Nat Commun2019https://conductscience.org/library/papers/30894526PubMed
434655133Observed Antibody Space: A diverse database of cleaned, annotated, and translated unpaired and paired antibody sequences.Protein Sci2022https://conductscience.org/library/papers/34655133PubMed
530760926High frequency of shared clonotypes in human B cell receptor repertoires.Nature2019https://conductscience.org/library/papers/30760926PubMed
639069558Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis.Nat Commun2024https://conductscience.org/library/papers/39069558PubMed
734741031Role of mutations and post-translational modifications in systemic AL amyloidosis studied by cryo-EM.Nat Commun2021https://conductscience.org/library/papers/34741031PubMed
831097697Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage.Nat Commun2019https://conductscience.org/library/papers/31097697PubMed
937516426The Cryo-EM STRUCTURE of Renal Amyloid Fibril Suggests Structurally Homogeneous Multiorgan Aggregation in AL Amyloidosis.J Mol Biol2023https://conductscience.org/library/papers/37516426PubMed
1039350582Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee.Amyloid2024https://conductscience.org/library/papers/39350582PubMed
1111549845Nomenclature of the human immunoglobulin kappa (IGK) genes.Exp Clin Immunogenet2001https://conductscience.org/library/papers/11549845PubMed
1238879609Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.Nat Commun2024https://conductscience.org/library/papers/38879609PubMed
1332878258Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions.Biomedicines2020https://conductscience.org/library/papers/32878258PubMed
141582976Mechanisms of disease: monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease.Hematol Oncol Clin North Am1992https://conductscience.org/library/papers/1582976PubMed
1535610346An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.Leukemia2022https://conductscience.org/library/papers/35610346PubMed
1619291508AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences.Amyloid2009https://conductscience.org/library/papers/19291508PubMed
1732211238Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease.PeerJ2020https://conductscience.org/library/papers/32211238PubMed
1820194151Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.Mayo Clin Proc2010https://conductscience.org/library/papers/20194151PubMed
1923451869Systemic amyloidoses.Annu Rev Biochem2013https://conductscience.org/library/papers/23451869PubMed
2032594098N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression.Leukemia2020https://conductscience.org/library/papers/32594098PubMed

See all 81 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42482306Glycosylation penetrance of N-X-S/T sequons in antibody variable domains: a structural survey of 19,265 human antibody structures reassessing the histidine/glutamine suppression hypothesis.MAbs2026https://conductscience.org/library/papers/42482306PubMed
42278643Multiple Myeloma Concomitant with AL Amyloidosis: Histopathological Aspects of the Common Plasma Cell Spectrum.Int J Mol Sci2026https://conductscience.org/library/papers/42278643PubMed
40861476Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.Front Immunol2025https://conductscience.org/library/papers/40861476PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39598451

GET https://conductscience.org/api/papers/v1/39598451/references?page=2